5 European Projects Found
Searched on 125080 European Projects
FINISHED
New approach to treatment of the blinding disease Retinopathy of Prematurity (ROP) (PREVENTROP)
Start date: Oct 1, 2012, End date: Sep 30, 2017,
"The overall objective is to develop a novel preventative intervention for the blinding disease retinopathy of prematurity (ROP) and other complications of prematurity. The PREVENTROP consortium proposes to conduct preclinical studies (pharmacological, pharmacodynamics, pharmacokinetics and toxicological) in models and/or clinical studies (including phase III clinical trial) of an EU designated o ...
Read Project
10
Partners Participants
FINISHED
Effective Perinatal Intensive Care in Europe: translating knowledge into evidence based practice (EPICE)
Start date: Jan 1, 2011, End date: Dec 31, 2015,
"Context: Very preterm infants face high risks of mortality and long-term neuro-developmental impairment. Rates of mortality and morbidity vary by a factor greater than two between European regions. This project’s overriding aim is to improve these infants’ survival and long-term health and development by ensuring that available medical knowledge is translated into effective perinatal care.Objecti ...
Read Project
14
Partners Participants
FINISHED
Treatment of NEonatal seizures with Medication Off-patent: evaluation of efficacy and safety of bumetanide (NEMO)
Start date: Oct 1, 2009, End date: Mar 31, 2015,
Neonatal hypoxic ischaemic encephalopathy (HIE) occurs in 2-3/1000 live births and is a major cause of both acute mortality and long-term neurodisability. Seizures are the hallmark of HIE. The clinical and electrographic seizure burden in babies with HIE can be considerable and is often not reduced by current antiepileptic drugs. Phenobarbitone remains the first line drug for neonatal seizures des ...
Read Project
15
Partners Participants
FINISHED
Targeting the tumour microenvironment to improve pancreatic cancer prognosis (EPC-TM-Net)
Start date: Feb 1, 2011, End date: Jul 31, 2014,
Pancreatic cancer is one of the most lethal human cancers with a five-year survival rate of less than 5%. Late presentation and a high level of resistance to chemotherapeutic drugs are among the major reasons for this dismal prognosis. The presence of the highest degree of desmoplasia among all solid tumours and the fact that chronic inflammatory pancreatic disease is associated with an increased ...
Read Project
17
Partners Participants
FINISHED
Improving the Continuity of patient care Through Identification and implementation of Novel patient handoff processes in Europe (HANDOVER)
Start date: Oct 1, 2008, End date: Sep 30, 2011,
Research has shown that every year 30,000 European patients suffer preventable harm during treatment. It is estimated there were potentially 1,735 avoidable deaths in 2004. The financial cost of avoidable adverse events is reckoned at €167 million, 1% of hospitals’ total budget, due to longer hospital stays and additional treatment. Many of these adverse events relate to handoff in care. Poor cont ...
Read Project
